InvestorQ : Can you tell me about the latest approval that Lupin got for the kidney disease drug?
Anamika Sodhani made post

Can you tell me about the latest approval that Lupin got for the kidney disease drug?

Answer
image
Angel dcosta answered.
3 months ago
Follow

One of India’s leading drug manufacturer, Lupin, announced that it had received approval from the US FDA to market Sevelamer Hydrochloride tablets. This medication is used to control serum phosphorus in patients afflicted by chronic kidney disease and is quite popular in the US markets. The US FDA has approved Lupin to market the generic version in strengths of 400 mg and 800 mg as per the regulatory filing made by Lupin.

This product is the generic version of Renagel, the patented formulation belonging to Genzyme Corporation of the US. Lupin plans to manufacture these medicines at its Nagpur plant in the state of Maharashtra. As per current estimates of market size, the Sevelamer Hydrochloride tablets had estimated annual sales of $80 million in the US. In a tight formulations market, this is likely to be a major boost for the trajectory of Lupin’s growth.

0 Views